Your browser doesn't support javascript.
loading
Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.
Lim, Tristan L; Lieberman, David B; Davis, Adam R; Loren, Alison W; Hausler, Ryan; Bigdeli, Ashkan; Li, Yimei; Powers, Jacquelyn; Raper, Anna; Carty, Shannon A; Nathanson, Katherine L; Bagg, Adam; Hexner, Elizabeth O; Maxwell, Kara N; Morrissette, Jennifer J D; Babushok, Daria V.
Affiliation
  • Lim TL; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lieberman DB; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Davis AR; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Loren AW; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Hausler R; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Bigdeli A; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Li Y; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Powers J; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Raper A; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Regeneron Genetics Center; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Carty SA; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Nathanson KL; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Bagg A; Division of Hematology-Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Hexner EO; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Maxwell KN; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Morrissette JJD; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Babushok DV; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Leukemia ; 36(1): 283-287, 2022 01.
Article in En | MEDLINE | ID: mdl-34193977
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Biomarkers, Tumor / Germ-Line Mutation / Hematologic Neoplasms / Genetic Predisposition to Disease / Telomere-Binding Proteins / Shelterin Complex / Lymphoma Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Biomarkers, Tumor / Germ-Line Mutation / Hematologic Neoplasms / Genetic Predisposition to Disease / Telomere-Binding Proteins / Shelterin Complex / Lymphoma Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States